SCHEMBL11180151

SCHEMBL11180151

COCc1ccc(CC(C)NCC(O)c2ccc(O)c(CO)c2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 19/20 0.56
▸ CYP3A4 P08684 4/20 0.54
▸ MAPK1 P28482 4/20 0.54
▸ ADRB1 P08588 3/20 0.54
▸ CYP2D6 P10635 2/20 0.54
▸ TSHR P16473 2/20 0.54
▸ ADRB3 P13945 2/20 0.54
▸ SLC6A4 P31645 2/20 0.54
▸ ADRA1A P35348 2/20 0.54
▸ SLC6A3 Q01959 2/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ ADORA3 P0DMS8 1/20 0.54
▸ PTGS1 P23219 1/20 0.54
▸ SLC6A2 P23975 1/20 0.54
▸ HTR2A P28223 1/20 0.54
▸ MC4R P32245 1/20 0.54
▸ OPRM1 P35372 1/20 0.54
▸ MC3R P41968 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11174404 0.89 ADRB2 (0.61) ADRB2CYP3A4MAPK1ADRB1CYP2D6
Salmefamol SCHEMBL20285629 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1ADRB1CYP2D6
Salmefamol SCHEMBL30361710 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1ADRB1CYP2D6
Salmefamol SCHEMBL18458 0.89 ADRB2 (0.67) ADRB2CYP3A4MAPK1ADRB1CYP2D6
SCHEMBL11180839 0.88 ADRB2 (0.63) ADRB2CYP3A4MAPK1ADRB1CYP2D6
SCHEMBL10661718 0.87 ADRB2 (0.63) ADRB2CYP3A4MAPK1ADRB1CYP2D6
SCHEMBL10662533 0.87 ADRB2 (0.63) ADRB2CYP3A4MAPK1ADRB1CYP2D6
SCHEMBL9664001 0.87 ADRB2 (0.63) ADRB2CYP3A4MAPK1ADRB1CYP2D6
SCHEMBL13754643 0.86 ADRB2 (0.72) ADRB2ADRB1CYP2D6TSHRHIF1A
SCHEMBL7143882 0.86 ADRB2 (0.72) ADRB2ADRB1CYP2D6TSHRHIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4396627-A HYPOGLYCEMIC AGENTS, TREATMENT OF OBECITY BEECHAM GROUP LIMITED (GB) 1983-08-02 — — US disclosed
EP-0021636-B1 SECONDARY AMINES, THEIR PREPARATION AND USE IN PHARMACEUTICAL COMPOSITIONS BEECHAM GROUP PLC (GB) 1982-12-01 — — EP disclosed
EP-0021636-A1 Secondary amines, their preparation and use in pharmaceutical compositions BEECHAM GROUP PLC (GB) 1981-01-07 — — EP disclosed
Send feedback